Export 62 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
J. Nyombayire, Anzala, O., Gazzard, B., Karita, E., Bergin, P., Hayes, P., Kopycinski, J., Omosa-Manyonyi, G., Jackson, A., Bizimana, J., Farah, B., Sayeed, E., Parks, C. L., Inoue, M., Hironaka, T., Hara, H., Shu, T., Matano, T., Dally, L., Barin, B., Park, H., Gilmour, J., Lombardo, A., Excler, J. - L., Fast, P., Laufer, D. S., and Cox, J. H., “First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.”, J Infect Dis, vol. 215, no. 1, pp. 95-104, 2017.
R. B. Nussenblatt, Thompson, D. J. S., Li, Z., Peterson, J. S., Robinson, R. R., Shames, R. S., Nagarajan, S., Tang, M. T., Mailman, M., Velez, G., Roy, C., Levy-Clarke, G. A., Suhler, E. B., Djalilian, A., Sen, H. N., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Mellow, S., Sran, P., and , “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration”, J Autoimmun, vol. 21, pp. 283-293, 2003.
R. B. Nussenblatt, Kim, J., Thompson, D. J. S., Davis, M. D., Chew, E., Ferris, F. L., and Buggage, R., “Vitamin E in the treatment of uveitis-associated macular edema.”, Am J Ophthalmol, vol. 141, no. 1, pp. 193-4, 2006.
R. Nussenblatt, Li, Z., Robinson, R., Shames, R., Tang, M., Mailman, M., Thompson, D., Peterson, J., Sen, H., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Sran, P., Waldmann, T., and Buggage, R., “Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy”, 2003.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., “Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.”, Proc Natl Acad Sci U S A, vol. 96, no. 13, pp. 7462-6, 1999.
R. B. Nussenblatt, Kim, J., Thompson, D. J. S., Davis, M. D., Chew, E., Ferris, F. L., and Buggage, R. R., “Randomized Cinical Trial of Vitamin E in the Treatment of Uveitis-Associated Macular Edema”, Am J Ophthalmol, vol. 141, pp. 193-194, 2006.
R. B. Nussenblatt, Rao, N., Foster, C. S., Sen, H. N., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Shames, R. S., and Buggage, R. R., “Uveitis therapy: a phase II study using subcutaneously administered daclizumab”, 2004.
R. B. Nussenblatt, Rao, N. A., Foster, C. S., Sen, H. N., Srivastava, S., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Robinson, R. R., Shames, R. S., and Buggage, R. R., “Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis”, 2003.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., “Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial”, Proceedings of the National Academy of Science USA, vol. 96, pp. 7462-66, 1999.
R. B. Nussenblatt, Thompson, D. J. S., Li, Z., Chan, C. Chao, Peterson, J. S., Robinson, R. R., Shames, R. S., Nagarajan, S., Tang, M. Tao, Mailman, M., Velez, G., Roy, C., Levy-Clarke, G. A., Suhler, E. B., Djalilian, A., Sen, H. Nida, Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Mellow, S., Sran, P., Waldmann, T. A., and Buggage, R. R., “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.”, J Autoimmun, vol. 21, no. 3, pp. 283-93, 2003.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Risso, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., “The use of monoclonal therapy in the treatment of intraocular inflammatory disease”, 2000.
R. B. Nussenblatt, Peterson, J. S., C Foster, S., Rao, N. A., See, R. F., Letko, E., and Buggage, R. R., “Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.”, Ophthalmology, vol. 112, no. 5, pp. 764-70, 2005.
R. B. Nussenblatt, Peterson, J. S., Foster, C. S., Rao, N. A., See, R. F., Letko, E., and Buggage, R. R., “Initial Evaluation of Subcutaneous Daclizumab Treatments for Noninfectious Uveitis: A Multicenter Noncomparative Interventional Case Series”, Ophthalmology, vol. 112, pp. 764-770, 2005.
R. N. Nussenblatt, Buggage, R., Thompson, D., Zhuqing, L., Ragheb, J., and Waldmann, T., “4 Year Daclizumab Therapy for Sight Threatening Uveitis”, 2002.
A. Nowak-Węgrzyn, Wood, R. A., Nadeau, K. C., Pongracic, J. A., Henning, A. K., Lindblad, R. W., Beyer, K., and Sampson, H. A., “Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy.”, J Allergy Clin Immunol, vol. 143, no. 2, pp. 651-661.e9, 2019.
T. E. Novak, Mathews, R., Martz, K., and Neu, A., “Progression of chronic kidney disease in children with vesicoureteral reflux: the North American Pediatric Renal Trials Collaborative Studies Database.”, J Urol, vol. 182, no. 4 Suppl, pp. 1678-81, 2009.
T. E. Novak, Neu, A., Martz, K., Fivush, B., Stablein, D., and Mathews, R. I., “Progression to End-stage Renal Disease in Children with Vesicoureteral Reflux (VUR): Insights from an Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Database”, in AAP, Boston, MA, 2008.
K. D. Nolph, Lindblad, A. S., and Novak, J. W., “Current concepts. Continuous ambulatory peritoneal dialysis.”, N Engl J Med, vol. 318, no. 24, pp. 1595-600, 1988.
C. J. Nobles, Schisterman, E. F., Ha, S., Louis, G. M. Buck, Sherman, S., and Mendola, P., “Time-varying cycle average and daily variation in ambient air pollution and fecundability.”, Hum Reprod, vol. 33, no. 1, pp. 166-176, 2018.
C. J. Nobles, Williams, A., Ouidir, M., Sherman, S., and Mendola, P., “Differential Effect of Ambient Air Pollution Exposure on Risk of Gestational Hypertension and Preeclampsia.”, Hypertension, vol. 74, no. 2, pp. 384-390, 2019.
C. J. Nobles, Grantz, K. L., Liu, D., Williams, A., Ouidir, M., Seeni, I., Sherman, S., and Mendola, P., “Ambient air pollution and fetal growth restriction: Physician diagnosis of fetal growth restriction versus population-based small-for-gestational age.”, Sci Total Environ, vol. 650, no. Pt 2, pp. 2641-2647, 2019.
C. J. Nobles, Schisterman, E. F., Ha, S., Kim, K., Mumford, S. L., Louis, G. M. Buck, Chen, Z., Liu, D., Sherman, S., and Mendola, P., “Ambient air pollution and semen quality.”, Environ Res, vol. 163, pp. 228-236, 2018.
D. L. Noah, Hill, H., Hines, D., E White, L., and Wolff, M. C., “Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.”, Clin Vaccine Immunol, vol. 16, no. 4, pp. 558-66, 2009.
D. L. Noah, Hill, H., Hines, D., White, E. L., and Wolff, M. C., “Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure”, Clin Vaccine Immunol, vol. 16, pp. 558-566, 2009.
S. E. K. Oden NL, “Estimating a mean for paired and unpaired eye data,”, 1996.